Shine reports Lu-177 production milestone
January 22, 2020 -- Medical isotope firm Shine Medical Technologies and partners GE Healthcare and the Institute of Organic Chemistry and Biochemistry in the Czech Republic said they have produced patient dose quantities of the lutetium-177 (Lu-177) therapeutic isotope.
January 22, 2020 -- Medical isotope firm Shine Medical Technologies and partners GE Healthcare and the Institute of Organic Chemistry and Biochemistry in the Czech Republic said they have produced patient dose quantities of the lutetium-177 (Lu-177) therapeutic isotope.
ASRT: Enrollment down for radiologic technology programs
January 15, 2020 -- The number of students enrolling in radiologic technology programs trended downward in 2019, according to a report released by the American Society of Radiologic Technologists (ASRT).
January 15, 2020 -- The number of students enrolling in radiologic technology programs trended downward in 2019, according to a report released by the American Society of Radiologic Technologists (ASRT).
ViewRay expects revenue growth in 2019, despite slow Q4
January 13, 2020 -- Image-guided radiation therapy vendor ViewRay reported in its preliminary results a growth in total revenue of roughly 8% for its fiscal 2019, despite a large drop in orders in its fourth quarter.
January 13, 2020 -- Image-guided radiation therapy vendor ViewRay reported in its preliminary results a growth in total revenue of roughly 8% for its fiscal 2019, despite a large drop in orders in its fourth quarter.
Accuray touts CyberKnife study results
January 9, 2020 -- Radiation oncology firm Accuray is touting the results of a prospective study in which stereotactic body radiation therapy performed with its CyberKnife system provided excellent disease control at the five-year mark for men with locally recurrent prostate cancer.
January 9, 2020 -- Radiation oncology firm Accuray is touting the results of a prospective study in which stereotactic body radiation therapy performed with its CyberKnife system provided excellent disease control at the five-year mark for men with locally recurrent prostate cancer.
Nanobiotix plans head and neck cancer treatment trial
January 8, 2020 -- Nanotech radiation therapy technology developer Nanobiotix said it will launch a trial for its NBTXR3 nanoparticle for use in treating late-stage head and neck cancers.
January 8, 2020 -- Nanotech radiation therapy technology developer Nanobiotix said it will launch a trial for its NBTXR3 nanoparticle for use in treating late-stage head and neck cancers.
Zr-89 immuno-PET could help predict cancer therapy outcomes
December 18, 2019 -- Researchers are one step closer to proving the worth of zirconium-89 (Zr-89) immuno-PET as a noninvasive approach to predict the effectiveness of therapy for cancerous tumors, according to a study published in the December issue of the Journal of Nuclear Medicine.
Discuss
December 18, 2019 -- Researchers are one step closer to proving the worth of zirconium-89 (Zr-89) immuno-PET as a noninvasive approach to predict the effectiveness of therapy for cancerous tumors, according to a study published in the December issue of the Journal of Nuclear Medicine.
Discuss IBA sells part of dosimetry unit
December 17, 2019 -- Proton therapy developer Ion Beam Applications (IBA) has sold its RadioMed unit to IZI Medical Products for an estimated price of $14 million to $16 million.
December 17, 2019 -- Proton therapy developer Ion Beam Applications (IBA) has sold its RadioMed unit to IZI Medical Products for an estimated price of $14 million to $16 million.
Elekta gets FDA nod for DWI-MR radiation therapy
December 16, 2019 -- Radiation oncology vendor Elekta has received 510(k) premarket notification from the U.S. Food and Drug Administration (FDA) for the clinical use of a diffusion-weighted imaging (DWI) MRI protocol with the company's Unity MR radiation therapy system.
December 16, 2019 -- Radiation oncology vendor Elekta has received 510(k) premarket notification from the U.S. Food and Drug Administration (FDA) for the clinical use of a diffusion-weighted imaging (DWI) MRI protocol with the company's Unity MR radiation therapy system.
GenesisCare acquires 21st Century Oncology
December 13, 2019 -- Australian cancer and cardiac care company GenesisCare has acquired U.S.-based radiation therapy and integrated cancer treatment provider 21st Century Oncology.
December 13, 2019 -- Australian cancer and cardiac care company GenesisCare has acquired U.S.-based radiation therapy and integrated cancer treatment provider 21st Century Oncology.
Senate confirms Hahn as FDA commissioner
December 13, 2019 -- The U.S. Senate has confirmed the Trump administration's nomination of radiation oncologist Dr. Stephen Hahn as commissioner of the U.S. Food and Drug Administration (FDA).
December 13, 2019 -- The U.S. Senate has confirmed the Trump administration's nomination of radiation oncologist Dr. Stephen Hahn as commissioner of the U.S. Food and Drug Administration (FDA).
Special Feature
IMV: Imaging boosts precision in radiation therapy
Radiation therapy is a relatively stable market, with procedure volume growing at an average annual rate of 2%. But major technological changes in radiation oncology are brewing under the surface, according to a new report by IMV Medical Information Division. Read more
VENDOR CONNECT